Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

IMMUNE STATUS OF PATIENTS WITH CHRONIC PROSTATITIS

View through CrossRef
ANOTATION.The most common urological disease among men of working age is chronic prostatitis, and its symptoms are a frequent reason for seeking urological care. PURPOSE OF THE RESEARCH. Тo assess the state of local and systemic immunity in patients with various forms of chronic prostatitis MATERIALS AND METHODS. 84 patients with chronic prostatitis, with a long recurrent course of the disease, were under observation. Among them, there were 15 (17.9%) with chronic bacterial prostatitis, 69 (82.1%) with chronic bacterial prostatitis, of which 44 patients had chronic inflammatory pelvic pain syndrome (CPPS) and 25 — non-inflammatory chronic pelvic pain syndrome (CPPS). The average age of the patients was 37.4±8.2 years, the duration of the disease from 4 to 7 years (5.7±1.3 years on average). An evaluation of symptoms and indicators of immune status was carried out in groups of patients according to the level of interferon-γ in the blood (IFN-γ), interleukins-6 and 8 (IL-6, IL-8), α-tumor necrosis factor (TNF-α) in the blood and ejaculate and also the level of secretory immunoglobulin A (sIgA) in ejaculate. RESULTS AND THEIR DISCUSSION. According to the questionnaire according to the questionnaire "Chronic Prostatitis Symptom Index" (NIH-CPSI, 1999) with an assessment of the quality of life of patients (QоL) in patients with chronic bacterial prostatitis (CBP), the total score was — 23.96±0.18, with chronic abacterial (CAP) — according to SICPP — 21.20±0.16 and SNICPP — 24.59±0.17, which corresponded to the average and severe degree (SNICPP and CBP) of the course of the disease. The results of indicators of systemic and local immunity of patients with chronic prostatitis indicated changes that depended on the form of chronic prostatitis, and were more pronounced at the local level. A more pronounced increase in pro-inflammatory cytokines (IL-6 and IL-8) both in the blood and in the ejaculate is observed in patients with the inflammatory form of chronic bacterial prostatitis (CBP), and an increase in secretory immunoglobulin A (sIgA) was observed in the ejaculate of patients with chronic bacterial prostatitis. Also, the most pronounced decrease in blood IFN-γ was also observed in patients with chronic bacterial prostatitis. An increase in the level of TNF-α, both in the blood and in the ejaculate, was observed in all patients with chronic prostatitis, but there was no significant difference in the indicators between the groups. There is no correlation between the level of cytokines and the activity of the leukocyte reaction in the secretion of the prostate gland. CONCLUSION. Changes in cytokine status are more pronounced at the local level and depend on the form of chronic prostatitis. Determination of indicators of immune status, especially in ejaculate, can increase the capabilities of the diagnostic algorithm for verifying the form of chronic prostatitis
Title: IMMUNE STATUS OF PATIENTS WITH CHRONIC PROSTATITIS
Description:
ANOTATION.
The most common urological disease among men of working age is chronic prostatitis, and its symptoms are a frequent reason for seeking urological care.
PURPOSE OF THE RESEARCH.
Тo assess the state of local and systemic immunity in patients with various forms of chronic prostatitis MATERIALS AND METHODS.
84 patients with chronic prostatitis, with a long recurrent course of the disease, were under observation.
Among them, there were 15 (17.
9%) with chronic bacterial prostatitis, 69 (82.
1%) with chronic bacterial prostatitis, of which 44 patients had chronic inflammatory pelvic pain syndrome (CPPS) and 25 — non-inflammatory chronic pelvic pain syndrome (CPPS).
The average age of the patients was 37.
4±8.
2 years, the duration of the disease from 4 to 7 years (5.
7±1.
3 years on average).
An evaluation of symptoms and indicators of immune status was carried out in groups of patients according to the level of interferon-γ in the blood (IFN-γ), interleukins-6 and 8 (IL-6, IL-8), α-tumor necrosis factor (TNF-α) in the blood and ejaculate and also the level of secretory immunoglobulin A (sIgA) in ejaculate.
RESULTS AND THEIR DISCUSSION.
According to the questionnaire according to the questionnaire "Chronic Prostatitis Symptom Index" (NIH-CPSI, 1999) with an assessment of the quality of life of patients (QоL) in patients with chronic bacterial prostatitis (CBP), the total score was — 23.
96±0.
18, with chronic abacterial (CAP) — according to SICPP — 21.
20±0.
16 and SNICPP — 24.
59±0.
17, which corresponded to the average and severe degree (SNICPP and CBP) of the course of the disease.
The results of indicators of systemic and local immunity of patients with chronic prostatitis indicated changes that depended on the form of chronic prostatitis, and were more pronounced at the local level.
A more pronounced increase in pro-inflammatory cytokines (IL-6 and IL-8) both in the blood and in the ejaculate is observed in patients with the inflammatory form of chronic bacterial prostatitis (CBP), and an increase in secretory immunoglobulin A (sIgA) was observed in the ejaculate of patients with chronic bacterial prostatitis.
Also, the most pronounced decrease in blood IFN-γ was also observed in patients with chronic bacterial prostatitis.
An increase in the level of TNF-α, both in the blood and in the ejaculate, was observed in all patients with chronic prostatitis, but there was no significant difference in the indicators between the groups.
There is no correlation between the level of cytokines and the activity of the leukocyte reaction in the secretion of the prostate gland.
CONCLUSION.
Changes in cytokine status are more pronounced at the local level and depend on the form of chronic prostatitis.
Determination of indicators of immune status, especially in ejaculate, can increase the capabilities of the diagnostic algorithm for verifying the form of chronic prostatitis.

Related Results

Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Complex conservative therapy of chronic abacterial prostatitis
Complex conservative therapy of chronic abacterial prostatitis
BACKGROUND: Improving the results of treatment of patients with chronic prostatitis is one of the important problems of modern urology. AIM: To compare the effect of ozone therapy...
Assessment of the psycho-emotional status of patients with chronic pelvic pain syndrome using magnetotherapy
Assessment of the psycho-emotional status of patients with chronic pelvic pain syndrome using magnetotherapy
BACKGROUND: Chronic pelvic pain syndrome against the background of chronic abacterial prostatitis is most often associated with emotional and behavioral disorders, asthenic syndrom...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract Introduction Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
CORRELATION BETWEEN PARACLINICAL PARAMETERS AND CLINICAL MANIFESTATIONS OF CHRONIC PROSTATITIS / CHRONIC PELVIC PAIN SYNDROME
CORRELATION BETWEEN PARACLINICAL PARAMETERS AND CLINICAL MANIFESTATIONS OF CHRONIC PROSTATITIS / CHRONIC PELVIC PAIN SYNDROME
Introduction. Chronic prostatitis/chronic pelvic pain syndrome is a prevalent multifactorial disorder affecting men of reproductive age and characterized by pelvic pain and lower u...
Coryneform bacteria in semen of chronic prostatitis patients
Coryneform bacteria in semen of chronic prostatitis patients
SummaryOur aim was to compare the presence and species composition of coryneform bacteria in chronic prostatitis patients and controls. Semen of 50 men with inflammatory prostatiti...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...

Back to Top